From cancer to rare diseases, Big Pharma puts profit before patients when deciding on new drugs

Instead of focusing on which illnesses are most in need of treatments or cures, too often drug firms base their decisions on money, explains award-winning investigative reporter Billy Kenber, author of ‘Sick Money’
— Read on inews.co.uk/news/health/big-pharma-profits-cancer-rare-diseases-new-drugs-1242812

Leave a Comment

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s